Haematopoietic repopulating activity in human cord blood CD133+ quiescent cells

Bone Marrow Transplantation

Volumn 43, Issue 8, 2009, Pages 627-635

  Boxall, S A ^a   Cook, G P ^a   Pearce, D ^b   Bonnet, D ^b   El Sherbiny, Y M ^a   Blundell, M P ^c   Howe, S J ^c   Leek, J P ^a   Markham, A F ^a,b   de Wynter, E A ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD133 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL FUNCTION; CELL LINEAGE; CELL REGENERATION; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ENZYME ACTIVITY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PHENOTYPE; PRIORITY JOURNAL; SCID MOUSE; T LYMPHOCYTE SUBPOPULATION; UMBILICAL CORD BLOOD;

ALDEHYDE DEHYDROGENASE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD34; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL CYCLE; FETAL BLOOD; GLYCOPROTEINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; PEPTIDES; PHENOTYPE;

EID: 67349132841     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.368     Document Type: Article

References (33)

1. Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NK et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: Analysis of engraftment and acute graft-versus-host disease. Blood 1996; 88: 795-802.
2. Rocha V, Wagner Jr JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000; 342: 1846-1854.
3. Sirchia G, Rebulla P. Placental/umbilical cord blood transplantation. Haematologica 1999; 84: 738-747.
4. Brunstein CG, Wagner JE. Umbilical cord blood transplantation and banking. Annu Rev Med 2006; 57: 403-417.
5. Wang J, Kimura T, Asada R, Harada S, Yokota S, Kawamoto Y et al. SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection. Blood 2003; 101: 2924-2931.
6. Zanjani ED, Almeida-Porada G, Livingston AG, Porada CD, Ogawa M. Engraftment and multilineage expression of human bone marrow CD34- cells in vivo. Ann N Y Acad Sci 1999; 872: 220-231; discussion 231-232.
7. Zanjani ED, Almeida-Porada G, Livingston AG, Flake AW, Ogawa M. Human bone marrow CD34 cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp Hematol 1998; 26: 353-360.
8. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996; 183: 1797-1806.
9. Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, Paradis G et al Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 1997; 3: 1337-1345.
10. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT et al A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997; 90: 5013-5021.
11. Gallacher L, Murdoch B, Wu DM, Karanu FN, Keeney M, Bhatia M. Isolation and characterization of human CD34()Lin() and CD34(+)Lin() hematopoietic stem cells using cell surface markers AC133 and CD7. Blood 2000; 95: 2813-2820.
12. Summers YJ, Heyworth CM, de Wynter EA, Chang J, Testa NG. Cord blood G(0) CD34+ cells have a thousand-fold higher capacity for generating progenitors in vitro than G(1) CD34+ cells. Stem Cells 2001; 19: 505-513.
13. Summers YJ, Heyworth CM, de Wynter EA, Hart CA, Chang J, Testa NG. AC133+ G0 cells from cord blood show a high incidence of long-term culture-initiating cells and a capacity for more than 100 million-fold amplification of colony-forming cells in vitro. Stem Cells 2004; 22: 704-715.
14. Storms RW, Green PD, Safford KM, Niedzwiecki D, Cogle CR, Colvin OM et al. Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34. Blood 2005; 106: 95-102.
15. Wilpshaar J, Falkenburg JH, Tong X, Noort WA, Breese R, Heilman D et al. Similar repopulating capacity of mitotically active and resting umbilical cord blood CD34(+) cells in NOD/SCID mice. Blood 2000; 96: 2100-2107.
16. Kollet O, Peled A, Byk T, Ben-Hur H, Greiner D, Shultz L et al. beta2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 2000; 95: 3102-3105.
17. Glimm H, Eisterer W, Lee K, Cashman J, Holyoake TL, Nicolini F et al Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice. J Clin Invest 2001; 107: 199-206.
18. Kerre TC, De Smet G, De Smedt M, Zippelius A, Pittet MJ, Langerak AW et al. Adapted NOD/SCID model supports development of phenotypically and functionally mature T cells from human umbilical cord blood CD34(+) cells. Blood 2002; 99: 1620-1626.
19. Bhatia M, Wang JC, Kapp U, Bonnet D, Dick JE. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 1997; 94: 5320-5325.
20. Dao MA, Arevalo J, Nolta JA. Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. Blood 2003; 101: 112-118.
21. Christ O, Lucke K, Imren S, Leung K, Hamilton M, Eaves A et al. Improved purification of hematopoietic stem cells based on their elevated aldehyde dehydrogenase activity. Haematologica 2007; 92: 1165-1172.
22. Gordon PR, Leimig T, Babarin-Dorner A, Houston J, Holladay M, Mueller I et al. Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells. Bone Marrow Transplant 2003; 31: 17-22.
23. Venezia TA, Merchant AA, Ramos CA, Whitehouse NL, Young AS, Shaw CA et al. Molecular signatures of proliferation and quiescence in hematopoietic stem cells. PLoS Biol 2004; 2: E301.
24. Cashman J, Dykstra B, Clark-Lewis I, Eaves A, Eaves C. Changes in the proliferative activity of human hematopoietic stem cells in NOD/SCID mice and enhancement of their transplantability after in vivo treatment with cell cycle inhibitors. J Exp Med 2002; 196: 1141-1149.
25. Passegue E, Wagers AJ, Giuriato S, Anderson WC, Weissman IL. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med 2005; 202: 1599-1611.
26. Gothot A, van der Loo JC, Clapp DW, Srour EF. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. Blood 1998; 92: 2641-2649.
27. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 1998; 4: 1038-1045.
28. Watt SM, Buhring HJ, Rappold I, Chan JY, Lee-Prudhoe J, Jones T et al CD164, a novel sialomucin on CD34(+) and erythroid subsets, is located on human chromosome 6q21. Blood 1998; 92: 849-866.
29. Buhring HJ, Seiffert M, Bock TA, Scheding S, Thiel A, Scheffold A et al. Expression of novel surface antigens on early hematopoietic cells. Ann N Y Acad Sci 1999; 872: 25-38; discussion 38-39.
30. Bhatia M. AC133 expression in human stem cells. Leukemia 2001; 15: 1685-1688.
31. Wilpshaar J, Bhatia M, Kanhai HH, Breese R, Heilman DK, Johnson CS et al. Engraftment potential of human fetal hematopoietic cells in NOD/ SCID mice is not restricted to mitotically quiescent cells. Blood 2002; 100: 120-127.
32. Hess DA, Wirthlin L, Craft TP, Herrbrich PE, Hohm SA, Lahey R et al Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 2006; 107: 2162-2169.
33. Pina C, May G, Soneji S, Hong D, Enver T. MLLT3 regulates early human erythroid and megakaryocyte cell fate. Cell Stem Cell 2008; 2: 264-273. Engraftmen